US FDA Adds Hand Sanitizer Import Alert Category After COVID-19 Production Surge Turned Deadly
Executive Summary
Action responds to methanol contamination in hand sanitizers manufactured in Mexico and marketed in the US under numerous brands that followed a loosening standards for the products to drive a swift increase in production and meet surging demand during the coronavirus pandemic.
You may also be interested in...
Lonza Trims Portfolio To Nutrition, Pharma, Biotech; Equity Groups Acquire Specialty Business
Private equity firms Bain Capital and Cinven Group Ltd. agree to acquire Lonza’s specialty ingredients business for $4.72Bn. Lonza says it will focus on its pharma, biotech and nutrition business, including a nutraceutical capsule manufacturing operation.
FDA, USP ‘Walk Companies Through The Basics’ Of GMPs After Widespread OTC Sanitizer Adulteration
Widespread findings in the US of methanol in OTC hand sanitizers labeled as containing ethyl or isopropyl alcohol are not without precedent as adulteration affecting a specific type of product. But surging sales hand sanitizers, sub-potent formulations as well as methanol-contaminated, prompted more immediate and comprehensive responses from FDA.
Pandemic Will Continue Limiting US FDA Inspections In Driving FY 2021 Drug GMP Warnings
FDA historically has based 100% of drug adulteration warning letters on inspections but COVID-19-related travel restrictions began changing that in FY 2020, when 2% of drug GMP warning letters were based on testing import samples. The change became even more pronounced in the first two months of FY 2021, with 59% of actions related to sample testing and 41% to inspections.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: